[Heart involvement in multisystem inflammatory syndrome in children correlated with SARS-CoV-2 infection: a review by ANMCO/SICP]

G Ital Cardiol (Rome). 2023 Jun;24(6):413-422. doi: 10.1714/4041.40199.
[Article in Italian]

Abstract

Acute clinical manifestations of COVID-19 are generally less severe in childhood, however a proportion of them can develop a severe systemic hyperinflammatory syndrome after SARS-CoV-2 infection, known as the multisystem inflammatory syndrome (multisystem inflammatory syndrome in children, MIS-C). Cardiovascular manifestations in MIS-C are frequent (34-82%), including myocardial dysfunction, coronary artery dilation or aneurysms, arrhythmias, conduction abnormalities, pericarditis and valvulitis. The most affected cases can develop cardiogenic shock needing intensive care unit admission, inotropic support and sometimes even mechanical circulatory support. The elevation of myocardial necrosis markers, the frequently transient left ventricular systolic dysfunction and the presence of changes on magnetic resonance imaging, support the hypothesis of an immune-mediated post-viral pathogenesis similar to myocarditis. Although MIS-C shows excellent short-term survival, further studies are needed to demonstrate complete reversibility of residual subclinical heart damage.

Publication types

  • Review
  • English Abstract

MeSH terms

  • COVID-19* / complications
  • Child
  • Coronary Aneurysm*
  • Heart
  • Humans
  • SARS-CoV-2
  • Systemic Inflammatory Response Syndrome / diagnosis

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related